Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...
To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dexcom received a warning letter on March 4 after the Food and Drug Administration found problems at ...
Lilly has taken a non-exclusive license to deploy Dexcom’s CGM systems – which include app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the ...
DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to ...
Financial giants have made a conspicuous bearish move on DexCom. Our analysis of options history for DexCom DXCM revealed 12 unusual trades. Delving into the details, we found 33% of traders were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results